Predictions
Alpha+omega Semiconductor
Start price
Target price
Perf. (%)
€45.31
05.04.22
05.04.22
€55.00
05.04.23
05.04.23
-7.37%
28.04.22
28.04.22
Could be worthwhile Investment >10% per year
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€3.03
23.04.21
23.04.21
€3.50
23.04.22
23.04.22
-20.62%
24.04.22
24.04.22
Could be worthwhile Investment >10% per year
ImmunityBio Inc.
Start price
Target price
Perf. (%)
€14.64
19.04.21
19.04.21
-
19.04.22
19.04.22
-68.10%
20.04.22
20.04.22
Could be very worthwhile Investment >20% year
Energous Corp.
Start price
Target price
Perf. (%)
€2.70
18.04.21
18.04.21
€3.50
18.04.22
18.04.22
-64.01%
19.04.22
19.04.22
Could be worthwhile Investment >10% per year
Clovis Oncology Inc.
Start price
Target price
Perf. (%)
€2.64
06.04.22
06.04.22
€1.00
06.04.23
06.04.23
-22.00%
18.04.22
18.04.22
Probably not worthwhile Investment
Decining EBIT margin than peer group
overvalued
Very low/no dividend yield expected
Clovis Oncology Inc.
Start price
Target price
Perf. (%)
€2.64
06.04.22
06.04.22
€0.000
06.04.23
06.04.23
-22.00%
18.04.22
18.04.22
Could be worthwhile Investment >10% per year
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Marathon Digital Holdings
Start price
Target price
Perf. (%)
€21.05
07.04.22
07.04.22
-
07.04.23
07.04.23
-7.36%
18.04.22
18.04.22
Risky Investment
Overstock.com
Start price
Target price
Perf. (%)
€45.87
10.02.22
10.02.22
-
10.02.23
10.02.23
-22.69%
17.04.22
17.04.22
Stable Large shareholder and/or long term investor
EBIT decline/stagnation expected
Few uniques
Sustainability is little important
Inovio Pharma
Start price
Target price
Perf. (%)
€6.45
27.11.21
27.11.21
€3.30
27.11.22
27.11.22
-52.69%
12.04.22
12.04.22
Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Novavax Inc.
Start price
Target price
Perf. (%)
€145.98
11.11.21
11.11.21
€75.00
11.11.22
11.11.22
-63.74%
11.04.22
11.04.22
Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
Aqua Metals Inc
Start price
Target price
Perf. (%)
€3.42
03.04.21
03.04.21
€4.50
03.04.22
03.04.22
-57.15%
04.04.22
04.04.22
Could be worthwhile Investment >10% per year
Marathon Digital Holdings
Start price
Target price
Perf. (%)
€28.50
28.03.22
28.03.22
-
28.03.23
28.03.23
-8.07%
02.04.22
02.04.22
Risky Investment
Vertex Energy Inc.
Start price
Target price
Perf. (%)
€8.05
29.03.22
29.03.22
-
29.03.23
29.03.23
24.22%
01.04.22
01.04.22
Probably not worthwhile Investment
Formfactor Inc.
Start price
Target price
Perf. (%)
€37.20
24.03.21
24.03.21
€40.00
24.03.22
24.03.22
7.53%
25.03.22
25.03.22
Could be worthwhile Investment >10% per year
Applied Optoelectronics Inc.
Start price
Target price
Perf. (%)
€7.17
21.03.21
21.03.21
-
21.03.22
21.03.22
-57.88%
22.03.22
22.03.22
Risky Investment
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.015
20.02.22
20.02.22
€7.50
20.03.22
20.03.22
61900.00%
21.03.22
21.03.22
Could be worthwhile Investment >10% per year
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€81.03
15.03.22
15.03.22
-
15.03.23
15.03.23
-14.84%
20.03.22
20.03.22
Could be worthwhile Investment >10% per year
Marathon Digital Holdings
Start price
Target price
Perf. (%)
€20.25
06.03.22
06.03.22
-
06.03.23
06.03.23
13.33%
17.03.22
17.03.22
Risky Investment
Chemocentryx Inc.
Start price
Target price
Perf. (%)
€20.53
14.03.22
14.03.22
€14.00
14.03.23
14.03.23
3.70%
16.03.22
16.03.22
Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
Cadiz Inc.
Start price
Target price
Perf. (%)
€5.35
01.11.21
01.11.21
-
01.11.22
01.11.22
-67.48%
16.03.22
16.03.22
Could be worthwhile Investment >10% per year
Marathon Digital Holdings
Start price
Target price
Perf. (%)
€36.28
15.03.21
15.03.21
-
15.03.22
15.03.22
-43.36%
16.03.22
16.03.22
Lower EBIT Margin than peer group
Probably not worthwhile Investment
Revenue decline/stagnation expected
High valuation
Chemocentryx Inc.
Start price
Target price
Perf. (%)
€30.25
13.10.21
13.10.21
€34.00
30.07.22
30.07.22
-32.13%
14.03.22
14.03.22
Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating